Chapter Evolving Roles of Spontaneous Reporting Systems to Assess and Monitor Drug Safety

This chapter aims to describe current and emerging roles of spontaneous reporting systems (SRSs) for assessing and monitoring drug safety. Moreover, it offers a perspective on the near future, which entails the so-called era of Big Data, keeping in mind both regulator and researcher viewpoints. Afte...

Full description

Bibliographic Details
Format: eBook
Language:English
Published: InTechOpen 2019
Subjects:
Online Access:Open Access: DOAB: description of the publication
Open Access: DOAB, download the publication
LEADER 02575namaa2200445uu 4500
001 doab70277
003 oapen
005 20210210
006 m o d
007 cr|mn|---annan
008 210210s2019 xx |||||o ||| 0|eng d
020 |a intechopen.79986 
024 7 |a 10.5772/intechopen.79986  |2 doi 
040 |a oapen  |c oapen 
041 0 |a eng 
042 |a dc 
072 7 |a MBN  |2 bicssc 
720 1 |a Cosimo Antonazzo, Ippazio  |4 aut 
720 1 |a De Ponti, Fabrizio  |4 aut 
720 1 |a Moretti, Ugo  |4 aut 
720 1 |a Pariente, Antoine  |4 aut 
720 1 |a Poluzzi, Elisabetta  |4 aut 
720 1 |a Raschi, Emanuel  |4 aut 
720 1 |a Salvo, Francesco  |4 aut 
245 0 0 |a Chapter Evolving Roles of Spontaneous Reporting Systems to Assess and Monitor Drug Safety 
260 |b InTechOpen  |c 2019 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |f Unrestricted online access  |2 star 
520 |a This chapter aims to describe current and emerging roles of spontaneous reporting systems (SRSs) for assessing and monitoring drug safety. Moreover, it offers a perspective on the near future, which entails the so-called era of Big Data, keeping in mind both regulator and researcher viewpoints. After a panorama on key data sources and analyses of post-marketing data of adverse drug reactions, a critical appraisal of methodological issues and debated future applications of SRSs will be presented, including the exploitation and challenges in evidence integration (i.e., merging and combining heterogeneous sources of data into a unique indicator of risk) and patient's reporting via social media. Finally, a call for a responsible use of these studies is offered, with a proposal on a set of minimum requirements to assess the quality of disproportionality analysis in terms of study conception, performing and reporting. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/3.0/  |2 cc  |u https://creativecommons.org/licenses/by/3.0/ 
546 |a English 
650 7 |a Public health and preventive medicine  |2 bicssc 
653 |a pharmacovigilance, signal, spontaneous reporting system, disproportionality analysis 
773 1 |7 nnaa 
793 0 |a DOAB Library. 
856 4 0 |u https://directory.doabooks.org/handle/20.500.12854/70277  |7 0  |z Open Access: DOAB: description of the publication 
856 4 0 |u https://library.oapen.org/bitstream/20.500.12657/49320/1/63595.pdf  |7 0  |z Open Access: DOAB, download the publication